Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion type Assertion NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_head.
- NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion wasGeneratedBy ECO_0000203 NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_provenance.
- NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion wasDerivedFrom befree-2016 NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_provenance.
- NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion SIO_000772 20813562 NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_provenance.
- NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion evidence source_evidence_literature NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_provenance.
- NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_assertion description "[Our study supports that mutations in the BRAF, KRAS, and PIK3CA genes make at least a minor contribution to OSCC tumorigenesis, and pathway-specific therapies targeting these 2 pathways should be considered for OSCC in a subset of patients with these mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836756.RAAkSXg4u148mgf0VI1eRkm02d70JQNcaSAp4rFnKFtvI130_provenance.